Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.

Burton E, Gawande PV, Yakandawala N, LoVetri K, Zhanel GG, Romeo T, Friesen AD, Madhyastha S.

Antimicrob Agents Chemother. 2006 May;50(5):1835-40.

2.

Anti-biofilm and anti-adherence activity of Glm-U inhibitors.

Suman E, D'souza SJ, Jacob P, Sushruth MR, Kotian MS.

Indian J Med Sci. 2011 Sep;65(9):387-92. doi: 10.4103/0019-5359.108954.

PMID:
23508481
3.

In vitro comparison of nitrofurazone- and silver alloy-coated foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms.

Johnson JR, Johnston B, Kuskowski MA.

Antimicrob Agents Chemother. 2012 Sep;56(9):4969-72. doi: 10.1128/AAC.00733-12. Epub 2012 Jul 2.

4.

Antibiofilm and antimicrobial efficacy of DispersinBĀ®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria.

Gawande PV, Leung KP, Madhyastha S.

Curr Microbiol. 2014 May;68(5):635-41. doi: 10.1007/s00284-014-0519-6. Epub 2014 Jan 21.

PMID:
24445333
5.

Antibiofilm effect of trans-cinnamaldehyde on uropathogenic Escherichia coli.

Amalaradjou MA, Narayanan A, Baskaran SA, Venkitanarayanan K.

J Urol. 2010 Jul;184(1):358-63. doi: 10.1016/j.juro.2010.03.006. Epub 2010 May 20.

PMID:
20488489
6.

Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results.

Hachem R, Reitzel R, Borne A, Jiang Y, Tinkey P, Uthamanthil R, Chandra J, Ghannoum M, Raad I.

Antimicrob Agents Chemother. 2009 Dec;53(12):5145-9. doi: 10.1128/AAC.00718-09. Epub 2009 Oct 5.

7.

The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters.

Sabbuba N, Hughes G, Stickler DJ.

BJU Int. 2002 Jan;89(1):55-60.

8.

Effect of ovotransferrin, protamine sulfate and EDTA combination on biofilm formation by catheter-associated bacteria.

Yakandawala N, Gawande PV, Lovetri K, Madhyastha S.

J Appl Microbiol. 2007 Mar;102(3):722-7.

9.

Efficacy of combination of chlorhexidine and protamine sulphate against device-associated pathogens.

Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S.

J Antimicrob Chemother. 2008 Mar;61(3):651-7. doi: 10.1093/jac/dkn006. Epub 2008 Feb 6.

PMID:
18258612
10.

Effect of triclosan on the formation of crystalline biofilms by mixed communities of urinary tract pathogens on urinary catheters.

Williams GJ, Stickler DJ.

J Med Microbiol. 2008 Sep;57(Pt 9):1135-40. doi: 10.1099/jmm.0.2008/002295-0.

PMID:
18719184
11.

Antimicrobial activity of imipenem against isolates from complicated urinary tract infections.

Ishihara S, Yamada T, Yokoi S, Ito M, Yasuda M, Nakano M, Kawada Y, Deguchi T.

Int J Antimicrob Agents. 2002 Jun;19(6):565-9.

PMID:
12135849
12.

Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi.

Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY.

Antimicrob Agents Chemother. 2012 Feb;56(2):935-41. doi: 10.1128/AAC.05836-11. Epub 2011 Nov 28.

13.

Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections.

Ahearn DG, Grace DT, Jennings MJ, Borazjani RN, Boles KJ, Rose LJ, Simmons RB, Ahanotu EN.

Curr Microbiol. 2000 Aug;41(2):120-5.

PMID:
10856378
14.

A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters.

Lee SJ, Kim SW, Cho YH, Shin WS, Lee SE, Kim CS, Hong SJ, Chung BH, Kim JJ, Yoon MS.

Int J Antimicrob Agents. 2004 Sep;24 Suppl 1:S65-9.

PMID:
15364311
15.

Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms.

Soboh F, Khoury AE, Zamboni AC, Davidson D, Mittelman MW.

Antimicrob Agents Chemother. 1995 Jun;39(6):1281-6.

16.

Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters.

Jones GL, Muller CT, O'Reilly M, Stickler DJ.

J Antimicrob Chemother. 2006 Feb;57(2):266-72. Epub 2005 Dec 9.

PMID:
16339844
17.

Role of antibiofilm-antimicrobial agents in controlling device-related infections.

Aslam S, Darouiche RO.

Int J Artif Organs. 2011 Sep;34(9):752-8. doi: 10.5301/ijao.5000024.

18.

Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination.

Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S.

J Antimicrob Chemother. 2009 Jul;64(1):88-93. doi: 10.1093/jac/dkp158. Epub 2009 May 14.

PMID:
19447791
19.
20.

Catheter-associated urinary tract infections: impact of catheter materials on their management.

Kumon H, Hashimoto H, Nishimura M, Monden K, Ono N.

Int J Antimicrob Agents. 2001 Apr;17(4):311-6.

PMID:
11295414

Supplemental Content

Support Center